Rizwana F. Sproule, VP Regulatory Affairs at Kite Pharma, Inc. (KITE), sold 5,084 shares at $55.07 ($281K) on 2016-01-15, disclosed to the SEC on 2016-01-19.
Open-market sale of $281k KITE by VP Regulatory Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.07 | 3,166 | $174K | 62.0% |
| 2 | $55.60 | 1,918 | $107K | 38.0% |
| Total | $55.27 avg | 5,084 | $281K | 100% |
| Filing → |
| KITE | SELL | 2016-01-19 | $531K | — | Filing → |
| KITE | SELL | 2016-01-19 | $107K | — | Filing → |
| KITE | SELL | 2015-12-17 | $610K | — | Filing → |